Braskem (BAK) Competitors $4.80 +0.64 (+15.23%) Closing price 03:59 PM EasternExtended Trading$4.84 +0.04 (+0.73%) As of 06:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends BAK vs. AVNT, MEOH, CC, PRM, PCT, TROX, NGVT, UAN, ECVT, and OECShould you be buying Braskem stock or one of its competitors? The main competitors of Braskem include Avient (AVNT), Methanex (MEOH), Chemours (CC), Perimeter Solutions (PRM), PureCycle Technologies (PCT), Tronox (TROX), Ingevity (NGVT), CVR Partners (UAN), Ecovyst (ECVT), and Orion (OEC). These companies are all part of the "chemicals" industry. Braskem vs. Avient Methanex Chemours Perimeter Solutions PureCycle Technologies Tronox Ingevity CVR Partners Ecovyst Orion Braskem (NYSE:BAK) and Avient (NYSE:AVNT) are both oils/energy companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, risk, community ranking, valuation and institutional ownership. Which has more volatility and risk, BAK or AVNT? Braskem has a beta of 2.01, meaning that its stock price is 101% more volatile than the S&P 500. Comparatively, Avient has a beta of 1.52, meaning that its stock price is 52% more volatile than the S&P 500. Do insiders & institutionals believe in BAK or AVNT? 95.5% of Avient shares are held by institutional investors. 0.0% of Braskem shares are held by insiders. Comparatively, 2.1% of Avient shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Is BAK or AVNT more profitable? Avient has a net margin of 4.66% compared to Braskem's net margin of -9.88%. Avient's return on equity of 10.56% beat Braskem's return on equity.Company Net Margins Return on Equity Return on Assets Braskem-9.88% -439.59% -4.12% Avient 4.66%10.56%4.17% Do analysts rate BAK or AVNT? Braskem presently has a consensus target price of $9.75, suggesting a potential upside of 103.34%. Avient has a consensus target price of $55.50, suggesting a potential upside of 29.01%. Given Braskem's higher probable upside, equities analysts clearly believe Braskem is more favorable than Avient.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Braskem 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Avient 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 Does the MarketBeat Community prefer BAK or AVNT? Braskem received 35 more outperform votes than Avient when rated by MarketBeat users. Likewise, 53.72% of users gave Braskem an outperform vote while only 46.88% of users gave Avient an outperform vote. CompanyUnderperformOutperformBraskemOutperform Votes6553.72% Underperform Votes5646.28% AvientOutperform Votes3046.88% Underperform Votes3453.13% Does the media prefer BAK or AVNT? In the previous week, Braskem had 3 more articles in the media than Avient. MarketBeat recorded 4 mentions for Braskem and 1 mentions for Avient. Avient's average media sentiment score of 0.73 beat Braskem's score of 0.46 indicating that Avient is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Braskem 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Avient 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable valuation and earnings, BAK or AVNT? Avient has lower revenue, but higher earnings than Braskem. Braskem is trading at a lower price-to-earnings ratio than Avient, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBraskem$14.14B0.14-$917.17M-$3.55-1.35Avient$3.14B1.25$75.70M$1.6226.56 SummaryAvient beats Braskem on 12 of the 18 factors compared between the two stocks. Get Braskem News Delivered to You Automatically Sign up to receive the latest news and ratings for BAK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BAK vs. The Competition Export to ExcelMetricBraskemIndustrial organic chemicals IndustryEnergy SectorNYSE ExchangeMarket Cap$1.92B$2.74B$9.26B$20.04BDividend YieldN/A3.48%11.45%3.61%P/E Ratio-1.3514.9613.3641.66Price / Sales0.14477.2750.8117.77Price / Cash13.2422.3711.0817.54Price / Book2.911.654.405.85Net Income-$917.17M$8.85M$946.90M$1.01B7 Day Performance22.63%5.19%3.26%3.48%1 Month Performance19.58%7.13%12.95%5.99%1 Year Performance-33.59%-3.22%472.38%20.49% Braskem Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BAKBraskem2.839 of 5 stars$4.81+15.2%$9.75+102.9%-42.2%$1.92B$14.14B-1.358,310Gap UpHigh Trading VolumeAVNTAvient4.8847 of 5 stars$39.96+4.7%$55.50+38.9%+15.8%$3.65B$3.21B24.679,700News CoverageMEOHMethanex4.5978 of 5 stars$47.92+0.4%$57.25+19.5%+12.1%$3.23B$3.69B22.391,451CCChemours3.9898 of 5 stars$18.41+4.4%$23.75+29.0%-33.6%$2.75B$5.75B36.826,200PRMPerimeter Solutions0.9776 of 5 stars$12.90+2.1%$14.50+12.4%+240.0%$1.89B$534.19M-11.42240Gap UpPCTPureCycle Technologies2.2241 of 5 stars$9.66-0.4%$12.50+29.4%+202.2%$1.68BN/A-6.44146News CoverageGap DownTROXTronox3.549 of 5 stars$9.31+2.6%$16.50+77.2%-20.9%$1.47B$3.08B-19.406,610NGVTIngevity1.2164 of 5 stars$39.68+4.4%$52.17+31.5%+15.2%$1.44B$1.48B-2.562,050Gap UpUANCVR Partners1.3816 of 5 stars$79.29+5.6%N/A+25.7%$1.36B$527.39M15.95300High Trading VolumeECVTEcovyst4.061 of 5 stars$7.56+0.8%$10.25+35.6%-11.6%$880.82M$695.34M16.44880News CoverageOECOrion3.636 of 5 stars$15.11+2.9%$23.50+55.5%-37.2%$872.15M$1.91B28.511,600 Related Companies and Tools Related Companies Avient Competitors Methanex Competitors Chemours Competitors Perimeter Solutions Competitors PureCycle Technologies Competitors Tronox Competitors Ingevity Competitors CVR Partners Competitors Ecovyst Competitors Orion Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:BAK) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Braskem S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Braskem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.